The role of platelets in the pathogenesis of viral hemorrhagic fevers
Citation: Zapata JC, Cox D, Salvato MS. The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS neglected tropical diseases. 2014 Jun;8(6).
Summary: This paper presents four major ways in which viruses in viral hemorrhagic fever (HFV), including Ebola, affect platelet development and function, with information derived from a systematic search and from conference presentations.
The article describes the impact and epidemiology of HFV, including geographical distribution. The pathogenesis of HFV and the structure and functions of platelets (thrombocytes) lead to detailed comments on the varied viruses covered in this article are given. It is clear that Ebola has not yet been studied to research three of the main mechanisms whereby HFV induce thrombocytopenia, and platelet-HFV interactions are poorly understood but seem to be different in each disease.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on Ebola but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about Ebola on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.